Regarding hypertension, elevated circulating IL-17A levels have been described in hypertensive patients and in patients with hypertension-associated diseases, including systemic lupus erythematosus, preeclampsia, and chronic allograft rejection (McMaster et al., 2015; Yao et al., 2015; Beringer et al., 2016: Loverre et al., 2011; Chehimi et al., 2017). Here, IL17A is linked to hypertensive disorder.